Phibro Animal Health Corporation (USD) Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.

Phibro Animal Health Corporation (USD) Active

Glenpointe Centre East, Teaneck, NJ, US, 07666-6712

Stock Price USD

Price Change

Last Dividend USD

Latest Rating

PAHC's stock peer is ANIP (ANI Pharmaceuticals, Inc.)

PAHC's stock peer is AUPH (Aurinia Pharmaceuticals Inc.)

PAHC's stock peer is AVDL (Avadel Pharmaceuticals plc)

PAHC's stock peer is BGM (BGM Group Ltd.)

PAHC's stock peer is MD (Pediatrix Medical Group, Inc.)

PAHC's stock peer is MNKD (MannKind Corporation)

PAHC's stock peer is OGN (Organon & Co.)

PAHC's stock peer is TLRY (Tilray Brands, Inc.)

Healthcare Drug Manufacturers - Specialty & Generic

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.

60%

Dcf Rating

100%

Return On Equity

100%

Return On Assets

20%

Debt To Equity

40%

Price To Earnings

20%

Price To Book

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
2026-06-03	2026-06-24	0.12	1.51 %	Quarterly
2026-03-04	2026-03-25	0.12	0.93 %	Quarterly
2025-11-26	2025-12-17	0.12	1.11 %	Quarterly
2025-09-03	2025-09-24	0.12	1.26 %	Quarterly
2025-06-04	2025-06-25	0.12	2.00 %	Quarterly
2025-03-05	2025-03-26	0.12	2.04 %	Quarterly
2024-11-27	2024-12-18	0.12	2.03 %	Quarterly
2024-09-04	2024-09-25	0.12	2.44 %	Quarterly
2024-06-05	2024-06-26	0.12	2.77 %	Quarterly
2024-03-06	2024-03-27	0.12	3.63 %	Quarterly
2023-11-29	2023-12-20	0.12	4.95 %	Quarterly
2023-09-06	2023-09-27	0.12	3.57 %	Quarterly
2023-06-07	2023-06-28	0.12	3.53 %	Quarterly
2023-03-01	2023-03-22	0.12	3.06 %	Quarterly
2022-11-30	2022-12-21	0.12	3.98 %	Quarterly
2022-09-07	2022-09-28	0.12	3.27 %	Quarterly
2022-06-01	2022-06-22	0.12	2.50 %	Quarterly
2022-03-02	2022-03-23	0.12	2.31 %	Quarterly
2021-11-24	2021-12-15	0.12	2.20 %	Quarterly
2021-09-01	2021-09-22	0.12	1.98 %	Quarterly
2021-06-02	2021-06-23	0.12	1.71 %	Quarterly
2021-03-03	2021-03-24	0.12	2.17 %	Quarterly
2020-11-25	2020-12-16	0.12	2.45 %	Quarterly
2020-09-02	2020-09-23	0.12	2.33 %	Quarterly
2020-06-03	2020-06-24	0.12	1.87 %	Quarterly
2020-03-04	2020-03-25	0.12	1.88 %	Quarterly
2019-11-27	2019-12-18	0.12	1.97 %	Quarterly
2019-09-04	2019-09-25	0.12	2.35 %	Quarterly
2019-06-05	2019-06-26	0.12	1.54 %	Quarterly
2019-03-06	2019-03-27	0.12	1.51 %	Quarterly
2018-11-28	2018-12-19	0.12	1.29 %	Quarterly
2018-09-05	2018-09-26	0.10	0.84 %	Quarterly
2018-06-06	2018-06-27	0.10	0.87 %	Quarterly
2018-03-07	2018-03-28	0.10	1.03 %	Quarterly
2017-12-06	2017-12-27	0.10	1.20 %	Quarterly
2017-09-06	2017-09-27	0.10	1.10 %	Quarterly
2017-05-31	2017-06-22	0.10	1.16 %	Quarterly
2017-03-01	2017-03-22	0.10	1.41 %	Quarterly
2016-11-30	2016-12-21	0.10	1.42 %	Quarterly
2016-09-07	2016-09-28	0.10	1.55 %	Quarterly
2016-06-01	2016-06-22	0.10	2.07 %	Quarterly
2016-03-02	2016-03-23	0.10	1.45 %	Quarterly
2015-12-02	2015-12-23	0.10	1.23 %	Quarterly
2015-09-02	2015-09-23	0.10	1.13 %	Quarterly
2015-06-03	2015-06-24	0.10	1.15 %	Quarterly
2015-03-04	2015-03-25	0.10	0.80 %	Quarterly
2014-12-03	2014-12-23	0.10	0.65 %	Quarterly
2014-09-03	2014-09-24	0.10	0.52 %	Quarterly

Recent News

Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Executive Vice President, Corporate Strategy & CEO Designate, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday, May 27, 2026, at 9:45 AM ET at Lotte New York Palace in New York. The live audio presentation will be available on the.

2026-05-21 16:30:00

Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities Health Care Conference. Executive Vice President, Corporate Strategy & CEO Designate Daniel Bendheim; Chief Operating Officer, Larry Miller and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday, May 13, 2026, at 1:40 PM ET at Wynn and Encore in Las Vegas. The live audio presentation will be availab.

2026-05-07 16:30:00

Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2026, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended March 31, 2026 (compared to the three months ended March 31, 2025): Net sales of $383.5 million, an increase of $35.7 million, or 10% Net income of $24.0 million, an increase of $3.1 million, or 15% Dilute.

2026-05-06 16:30:00

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2026, to stockholders of record at the close of business on June 3, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livest.

2026-05-05 16:30:00

Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein, dairy and petfood producers address greenhouse gas emissions through practical, science-based solutions that integrate seamlessly into existing feed and production systems. As part of the SSP launch, Phibro is introducing Verratain™ Verified Sustainability Solutions, the Company's fir.

2026-05-05 16:15:00

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 6, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 7, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-202.

2026-04-29 16:30:00

Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications. The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation, manufacture, marketing and use of performance enhancing feed additives containing antimicrobials classified as importan.

2026-04-27 16:30:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions